Specialisation
Retina and Vitreous.
Full title
Phase IV, randomised, double-blind trial with simulated control for the analysis of the efficacy, safety and tolerability of aflibercept intravenous monotherapy compared to aflibercept and concomitant photodynamic therapy in patients with polypodal choroidal vasculopathy.
Promoter
EVICR (European Vision Institute Clinical Research).
Start date
May 2016
End date
January 2019
Researchers
Main: Dra. Anniken Burés.